A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio: On-demand Programme
Published: 19 March 2021
16m 23sPart 2 The PASCAL Platform – Successfully and Confidently Treat MR Peter Lüdike
14m 31sPart 3 The PASCAL Ace Implant System – Therapy to Successfully Treat TR Philipp Lurz
This on-demand version of the broadcast 'A Peek into the Future – Repair and Replacement of the Mitral and Tricuspid Valves with the Edwards Portfolio' comprises an internationally-respected faculty, as they review the PASCAL platform focusing on the recently CE mark approved PASCAL Ace implant system for the treatment of mitral and tricuspid regurgitation. Under the stewardship of programme Chair, Prof Nicolas van Mieghem, Erasmus Medical Center, Rotterdam, this programme examines the role of the PASCAL platform the the treatment of MR, the PASCAL Ace Implant System in the treatment of TR, valve replacement with EVOQUE, and includes a live procedure from Heidelberg University Hospital to best enhance practical learnings.
Pipeline products for tricuspid transcatheter replacement from Edwards Lifesciences will be shown and briefly discussed.
- Outline the pathogenic nature and clinical risk of extended exposure to elevated LDL-C
- Describe the clinical challenges in achieving guideline-based LDL-C goals
- Compare and contrast LDL-C lowering therapies
- Interventional Cardiologists
- General Cardiologists
- Heart Failure Specialists
More from this programme
Introduction – A Peek into the Future Repair and Replacement of the Mitral & Tricuspid Valves With the Edwards Portfolio
The PASCAL Platform – Successfully and Confidently Treat MR
The PASCAL Ace Implant System – Therapy to Successfully Treat TR
Looking into the Future – Valve Replacement with the EVOQUE
Case – PASCAL Ace Implant System for the Treatment of TR
Ralph von Bardeleben
Head of the Centre of Structural Heart Disease Interventions and the Heart Valve Centre
Prof Ralph Stephan von Bardeleben is the Head of the Center of Structural Heart Disease Interventions and the Heart Valve Center in Mainz, Germany
Prof Bardeleben is Past-President of the German working group on Echocardiography of the German Society of Cardiology and a member of several medical societies. He serves on the Clinical Program commission and at your region program of the ESC and is a reviewer for several peer-reviewed journals. Newly elected co-editor-in-chief of Echocardiography Journal.
He participates as PI, steering committee member and core laboratory in several medical device trials, including a German Federal Institute for Drugs and Medical Devices (BfArM)-approved first- or early-in-human medical device implant trials.